PND4 ESTIMATED COST SAVINGS WHEN TREATING RESTLESS LEGS SYNDROME (RLS) WITH GABAPENTIN ENACARBIL IN THE US

May 1, 2010, 00:00
10.1016/S1098-3015(10)72666-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)72666-8/fulltext
Title : PND4 ESTIMATED COST SAVINGS WHEN TREATING RESTLESS LEGS SYNDROME (RLS) WITH GABAPENTIN ENACARBIL IN THE US
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72666-8&doi=10.1016/S1098-3015(10)72666-8
First page :
Section Title :
Open access? : No
Section Order : 214
Categories :
Tags :
Regions :
ViH Article Tags :